Divestment of Acrylate Monomers completed

Synthomer has completed its Czech Acrylate Monomers divestment but omits deal financials.

What the company is saying

Synthomer plc announces the completion of its divestment of Synthomer a.s., the operating company for its Acrylate Monomers business in the Czech Republic, stating this aligns with terms announced on 19 June 2026. The company highlights that the Acrylate Monomers business was already classified as a discontinued operation in its interim results for the six months ended 30 June 2026. Synthomer frames itself as a leading supplier of specialised polymers and ingredients, serving coatings, construction, adhesives, and health sectors, and emphasises its global reach with 3,500 employees, five innovation centres, and 28 manufacturing sites. The release stresses scale—over 6,000 blue-chip customers and £1.7bn in continuing revenue in 2025—and innovation, with 20% of sales volumes from new and patent-protected products. Sustainability credentials are foregrounded, referencing 2030 decarbonisation targets approved by the Science Based Targets initiative and the London Stock Exchange Green Economy Mark held since 2021. The announcement is factual and confident but does not disclose the financial terms or strategic rationale of the divestment.

What the data suggests

The only realised transaction is the completed divestment of the Acrylate Monomers business in the Czech Republic, with no financial terms or proceeds disclosed. Synthomer's operational scale is evidenced by 3,500 employees, 28 manufacturing sites, and five innovation centres across Europe, North America, Middle East, and Asia. The company serves over 6,000 blue-chip customers and reported £1.7bn in continuing revenue for 2025. Product innovation is quantified, with 20% of sales volumes from new and patent-protected products. The business is structured into three divisions: Coatings & Construction Solutions, Adhesive Solutions, and Health & Protection and Performance Materials. The sustainability narrative is supported by the approval of 2030 decarbonisation targets by the Science Based Targets initiative and the Green Economy Mark since 2021. No figures are provided for the size, profitability, or impact of the divested business, nor for the financial effect on continuing operations, limiting insight into value creation or strategic direction.

Analysis

The announcement's tone is positive, highlighting the completion of a divestment and providing a broad overview of Synthomer's scale, innovation, and sustainability credentials. The core realised fact is the completion of the divestment of Synthomer a.s., which is clearly supported. Most other claims (employee count, customer base, revenue, product mix) are factual and current. The only forward-looking element is the reference to 2030 decarbonisation targets, but these are described as already approved by the Science Based Targets initiative, reducing their aspirational risk. However, the release includes promotional language ('leading supplier', 'high-performance, highly specialised', 'blue-chip customers') without comparative or substantiating data. No profitability, cash flow, or financial impact of the divestment is disclosed, limiting the ability to assess value creation. The overall hype is moderate, as the narrative inflates the company's status and innovation without new measurable progress.

Risk flags

• ●The absence of disclosed financial terms for the divestment creates uncertainty about the proceeds received, the profit or loss on sale, and the impact on Synthomer's balance sheet or future earnings. This lack of transparency limits investor ability to assess whether the transaction adds or destroys value.
• ●No information is provided on how Synthomer will redeploy capital or reshape its business following the divestment, leaving the strategic rationale and future direction unclear. This increases execution risk around the company's ability to generate returns from its remaining portfolio.
• ●The announcement relies heavily on scale, innovation, and sustainability credentials without providing comparative data or evidence of market leadership. This promotional framing, combined with the omission of key financial metrics, raises the risk that the narrative overstates the company's competitive or financial position.

Bottom line

Synthomer has completed the sale of its Acrylate Monomers business in the Czech Republic, but the lack of disclosed financial terms means investors cannot assess the immediate value or strategic impact of the deal. The company remains a large, diversified supplier with 3,500 employees, 28 manufacturing sites, and £1.7bn in continuing revenue, serving over 6,000 customers. Around 20% of its sales volumes are from new and patent-protected products, and it continues to emphasise sustainability with approved 2030 decarbonisation targets. The announcement is credible in confirming the transaction's completion but leaves a significant information gap regarding proceeds, profitability, and future capital allocation. Investors should focus on upcoming disclosures about how Synthomer will use any proceeds and what the divestment means for its long-term growth and financial profile. The most important takeaway is that the transaction is done, but the value to shareholders remains opaque until further detail is provided.

Announcement summary

(LSE:SYNT) Synthomer plc announces the completion of its divestment of Synthomer a.s., the operating company for its Acrylate Monomers business based in the Czech Republic, in line with the terms announced on 19 June 2026. The Acrylate Monomers business was classified as a discontinued operation in Synthomer's interim results for the six months ended 30 June 2026, as announced on 4 August. Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients for sectors such as coatings, construction, adhesives, and health and protection. The company is headquartered in London, United Kingdom, and has been listed on the London Stock Exchange since 1971. Synthomer employs approximately 3,500 employees across five innovation centres of excellence and 28 manufacturing sites in Europe, North America, Middle East, and Asia. The company serves more than 6,000 blue-chip customers and reported £1.7bn in continuing revenue in 2025. Synthomer operates through three divisions: Coatings & Construction Solutions, Adhesive Solutions, and Health & Protection and Performance Materials. Around 20% of Synthomer's sales volumes are from new and patent protected products. The company's innovation centres are located in the United Kingdom, China, Germany, Malaysia, and Ohio, USA. Synthomer's 2030 decarbonisation targets have been approved by the Science Based Targets initiative as being in line with the Paris Agreement. Since 2021, Synthomer has held the London Stock Exchange Green Economy Mark. Faisal Tabbah is Vice President Investor Relations. Nick Hasell is with FTI Consulting. The Legal Entity Identifier (LEI) for Synthomer plc is 213800EHT3TI1KPQQJ56.

Disagree with this article?